Investments
1Portfolio Exits
1
Want to inform investors similar to Hans Schikan about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Hans Schikan News
Apr 26, 2022
Xinvento, an Amsterdam, Netherlands-based biotech company, raised a Seed funding of undisclosed amount. Backers included Ed Kaye, John Maraganore, David Meeker, Hans Schikan, James Shannon, Onno van de Stolpe, Daniel de Boer and Dinko Valerio.
Hans Schikan Investments
1 Investments
Hans Schikan has made 1 investments. Their latest investment was in Xinvento as part of their Angel on April 4, 2022.
Hans Schikan Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/21/2022 | Angel | Xinvento | Yes | 2 |
Date | 4/21/2022 |
|---|---|
Round | Angel |
Company | Xinvento |
Amount | |
New? | Yes |
Co-Investors | |
Sources | 2 |
Hans Schikan Portfolio Exits
1 Portfolio Exit
Hans Schikan has 1 portfolio exit. Their latest portfolio exit was Xinvento on February 27, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/27/2023 | Acquired | 8 |
Date | 2/27/2023 |
|---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 8 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.